Headline
The latest stories from AHA Today.
Jim Skogsbergh, president and CEO of Advocate Aurora Health, will join AHA Board Chair Melinda Estes, M.D., Oct. 22 at 3:30 p.m. ET to discuss COVID-19’s impact on health trends and key strategies for reimagining and innovating care during and beyond the pandemic.
The Department of Health and Human Services announced a pair of innovation challenges aimed at improving maternal and infant health.
Access to potentially life-saving mammograms is more difficult for women who face social determinants of health such as low-income, lack of transportation or the inability to take time off from work.
The Centers for Medicare & Medicaid Services announced Georgia can move forward with a limited Medicaid expansion plan under which enrollees up to 100% of the federal poverty level must comply with, and report, work or other qualifying activities.
A recent article on hospital field finances ignores the diverse experiences of hospitals during the pandemic, particularly those under significant financial pressure, writes Aaron Wesolowski, AHA’s vice president of policy research, analytics and strategy.
The National Institutes of Health announced the start of an adaptive phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19.
The Food and Drug Administration Oct. 15 removed epinephrine from the lists of drugs authorized for temporary compounding during the COVID-19 public health emergency by outsourcing facilities and state-licensed pharmacies or federal facilities not registered as outsourcing facilities.
The Food and Drug Administration Oct. 15 said it reissued its emergency use authorization for certain, Chinese-manufactured filtering face-piece respirators that lack National Institute for Occupational Safety and Health approval.
The Centers for Medicare & Medicaid Services Oct. 15 said it will incentivize labs to deliver quicker results to patients undergoing COVID-19 diagnostic testing.
The Department of Health and Human Services announced agreements with CVS and Walgreens to provide and administer COVID-19 vaccines to long-term care facility residents.